9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 105 filers reported holding 9 METERS BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,218,000 | -64.0% | 8,505,729 | -17.2% | 0.04% | -60.0% |
Q1 2022 | $6,158,000 | -38.8% | 10,275,887 | 0.0% | 0.10% | -22.5% |
Q4 2021 | $10,057,000 | -9.7% | 10,275,887 | +20.0% | 0.13% | +5.7% |
Q3 2021 | $11,136,000 | +18.2% | 8,565,974 | 0.0% | 0.12% | +28.4% |
Q2 2021 | $9,423,000 | -68.7% | 8,565,974 | -66.7% | 0.10% | -66.2% |
Q1 2021 | $30,089,000 | +36.2% | 25,716,755 | 0.0% | 0.28% | +45.6% |
Q4 2020 | $22,091,000 | +7.8% | 25,716,755 | 0.0% | 0.19% | -25.2% |
Q3 2020 | $20,489,000 | +40.4% | 25,716,755 | 0.0% | 0.26% | +25.9% |
Q2 2020 | $14,591,000 | – | 25,716,755 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 2,750,000 | $3,575,000 | 1.04% |
ODonnell Financial Services, LLC | 840,727 | $1,093,000 | 0.52% |
Orbimed Advisors | 8,565,974 | $11,136,000 | 0.12% |
Paradigm, Strategies in Wealth Management, LLC | 30,800 | $40,000 | 0.04% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 15,000,000 | $19,500,000 | 0.04% |
Ascent Wealth Partners, LLC | 85,224 | $111,000 | 0.02% |
CHARTWELL INVESTMENT PARTNERS, LLC | 475,839 | $619,000 | 0.02% |
Prentice Wealth Management LLC | 29,000 | $38,000 | 0.02% |
Valeo Financial Advisors, LLC | 198,148 | $258,000 | 0.02% |
Almanack Investment Partners, LLC. | 40,850 | $53,000 | 0.01% |